Lianxin Wang

Beijing, 100700, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database.

Real-world safety profile of fezolinetant: a disproportionality analysis based on the FAERS database.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 05, 2026

Correction: Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.

Correction: Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.

Journal: JMIR research protocols

Published: April 02, 2026

Chinese herbal medicine and risk of coronary heart disease in patients with hyperlipidemia: A target trial emulation.

Chinese herbal medicine and risk of coronary heart disease in patients with hyperlipidemia: A target trial emulation.

Journal: Journal of ethnopharmacology

Published: January 21, 2026

Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.

Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study.

Journal: JMIR research protocols

Published: September 25, 2025

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study.

Clinical Safety of Pudilan Xiaoyan Oral Liquid for the Treatment of Upper Respiratory Tract Infection in the Real World: Protocol for a Prospective, Observational, Registry Study.

Journal: JMIR research protocols

Published: August 26, 2024

The 2-Step Mendelian Randomisation Study Assesses Genetic Causality and Potential Mediators of Periodontal Disease and Atrial Fibrillation.

The 2-Step Mendelian Randomisation Study Assesses Genetic Causality and Potential Mediators of Periodontal Disease and Atrial Fibrillation.

Journal: International dental journal

Published: July 18, 2024

Tripterygium wilfordii Hook.f induced kidney injury through mediating inflammation via PI3K-Akt/HIF-1/TNF signaling pathway: A study of network toxicology and molecular docking.

Tripterygium wilfordii Hook.f induced kidney injury through mediating inflammation via PI3K-Akt/HIF-1/TNF signaling pathway: A study of network toxicology and molecular docking.

Journal: Medicine

Published: February 09, 2024

Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial.

Clinical effectiveness and safety of salvia miltiorrhiza depside salt combined with aspirin in patients with stable angina pectoris: A multicenter, pragmatic, randomized controlled trial.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 18, 2020

Salvianolic Acids for Injection Combined with Conventional Treatment for Patients with Acute Cerebral Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Salvianolic Acids for Injection Combined with Conventional Treatment for Patients with Acute Cerebral Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: October 23, 2019

Sanjin tablet combined with antibiotics for treating patients with acute lower urinary tract infections: A meta-analysis and GRADE evidence profile.

Sanjin tablet combined with antibiotics for treating patients with acute lower urinary tract infections: A meta-analysis and GRADE evidence profile.

Journal: Experimental and therapeutic medicine

Published: June 03, 2019

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

Journal: Molecular medicine reports

Published: September 14, 2018

[Retracted] Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

[Retracted] Baicalin inhibits influenza virus A replication via activation of type I IFN signaling by reducing miR‑146a.

Journal: Molecular medicine reports

Published: September 14, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026